Trending intel short linkNo signup · Email subscription
47k following · New Drug Approval / China / NMPA

Progress of new drug approvals by China NMPA in the second half of 2026

Follow up on the review progress and approval results of 8 blockbuster drugs rushing to market, and observe changes in indication coverage and market competition landscape.

47k following105.4k views
By clicking “Confirm”, you acknowledge that you have read and agree to
/ /
Unlimited Free Public IntelligenceOnly key changes trigger emailsUnsubscribe anytime
Monitor official signalsTrack announcements, filings, company statements, prices, and investor updates.
AI summaryFilter repeated noise and provide concise conclusions with source confidence.
Notify only when usefulNo daily spam. You only get emailed when meaningful progress appears.